Spots Global Cancer Trial Database for Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
Official Title: Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
Study ID: NCT05211271
Conditions
Interventions
Study Description
Brief Summary: Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.
Detailed Description: The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by thermal ablation. Informed consent was signed by each participant. Just after treatment, they were inquired about the level of pain during the procedure, and their level of satisfaction with the treatment. They were followed-up at 6 weeks for any complication and re-assessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Kamenge University Hospital, Bujumbura, , Burundi
Contact Details
Name: Sylvestre Bazikamwe, MD
Affiliation: Kamenge University Hospital, Burundi University, Bujumbura, Burundi
Role: PRINCIPAL_INVESTIGATOR
Name: Catherine Sauvaget, MD, PhD
Affiliation: International Agency for Research on Cancer
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
